Contributions of authors
Professor David Osborn (Professor of Psychiatric Epidemiology) was the chief investigator.
Ms Alexandra Burton (Research Associate/Programme Manager) managed the programme of work.
Dr Kate Walters (Reader in Primary Care and Epidemiology) was the deputy chief investigator.
Dr Lou Atkins (Senior Teaching Fellow in Behaviour Change) led on the systematic review, development of the fidelity protocol and delivered the trial intervention training.
Professor Thomas Barnes (Professor of Clinical Psychiatry) and Professor Thomas Craig (Professor of Community and Social Psychiatry) provided clinical and trial expertise to the intervention development and trial.
Dr Ruth Blackburn (Research Associate in Epidemiology and Statistics) led the statin prescribing and effectiveness database work.
Dr Hazel Gilbert (Honorary Principal Research Associate in Health Psychology) provided health psychology expertise on smoking cessation within the intervention development and trial.
Dr Ben Gray (Senior Research Officer, Service User Expert) and Dr Vanessa Pinfold (Research Director) led on all aspects of PPI within the programme.
Dr Sarah Hardoon (Senior Research Associate in Epidemiology and Statistics) carried out statistical analysis for the risk score work supervised by Professor Irene Petersen (Reader in Epidemiology and Statistics).
Ms Samira Heinkel (Trial Co-ordinator) co-ordinated the trial and led on the fidelity analysis.
Professor Richard Holt (Professor in Diabetes and Endocrinology), Professor Michael King (Professor of Primary Care Psychiatry), Professor Irwin Nazareth (Professor of Primary Care and Population Science) and Professor Robert Peveler (Professor of Liaison Psychiatry) provided clinical and trial expertise to the intervention development, systematic review and trial.
Ms Rachael Hunter (Principal Research Associate in Health Economics) led on the cost-effectiveness analysis for the trial and supervised the economic evaluation of the risk score work.
Ms Claire Johnston (Honorary Clinical Professor of Nursing) and Dr Judy Leibowitz (Consultant Clinical Psychologist) provided clinical expertise on the development of the intervention.
Dr Louise Marston (Senior Research Associate in Statistics) led on the statistical analysis of trial data supervised by Professor Rumana Omar (Professor of Medical Statistics).
Professor Susan Michie (Professor of Health Psychology) provided expertise on behaviour change theory in the intervention development and trial.
Professor Richard Morris (Professor in Medical Statistics) provided expert advice on the risk score work.
Professor Steve Morris (Professor of Health Economics) advised on the economic evaluation of the trial.
Dr Fiona Stevenson (Reader in Medical Sociology) provided qualitative expertise on the focus group work and trial.
Dr Ella Zomer (Research Fellow in Health Economics) led on the economic evaluation of the risk score work.
All authors contributed to the development of the trial intervention and training programme, and provided a critical review and final approval of the report.
Professor David Osborn is supported by the University College London Hospital NIHR Biomedical Research Centre and he was also in part supported by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Barts Health NHS Trust.
Contributions of others
We would like to thank Dr Sheila Hardy and Ms Vanessa Robinson for their input into the development of the intervention manual and training programme and for delivering the intervention training alongside members of the research team. We would also like to thank Ms Tayla McCloud for her assistance with the fidelity analysis and patient follow-ups, Mr Stuart Brownings for carrying out patient follow-ups in the trial, Dr Maxine Howard and Vinca Tang for their contribution to the systematic review searches and write-up and Ms Nishat Parwin for administrative support to the trial. We would also like to thank Professor Simon Gilbody for chairing our Trial Steering Group, and Ms Jackie Hardy, Dr Fiona Gaughran and Mr Mark Mullee for their advice as Trial Steering Group members. We thank the LEAP for their valuable contributions throughout the programme of work and the CRN network research nurses and researchers for supporting the recruitment and follow-up of trial patients. Finally, we would like to thank all GP practice staff and patients who participated in the focus groups and the trial.
Data-sharing statement
Requests for access to available data should be addressed to the corresponding author.
Patient data
This work uses data provided by patients and collected by the NHS as part of their care and support. Using patient data is vital to improve health and care for everyone. There is huge potential to make better use of information from people’s patient records, to understand more about disease, develop new treatments, monitor safety, and plan NHS services. Patient data should be kept safe and secure, to protect everyone’s privacy, and it’s important that there are safeguards to make sure that it is stored and used responsibly. Everyone should be able to find out about how patient data are used. #datasaveslives You can find out more about the background to this citation here: https://understandingpatientdata.org.uk/data-citation.
Disclaimers
This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, CCF, NETSCC, the PGfAR or the Department of Health and Social Care. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, NETSCC, the PHR programme or the Department of Health and Social Care.
